Provided by Tiger Fintech (Singapore) Pte. Ltd.

ANI Pharmaceuticals

66.30
-5.2300-7.31%
Post-market: 66.300.00000.00%19:06 EDT
Volume:756.75K
Turnover:51.64M
Market Cap:1.43B
PE:-63.57
High:77.00
Open:76.01
Low:65.96
Close:71.53
Loading ...

ANI Pharmaceuticals Reports Record Growth in Earnings Call

TIPRANKS
·
10 May

BUZZ-U.S. STOCKS ON THE MOVE-Compass, Rumble, Tesla

Reuters
·
10 May

Cortrophin Demand Is Soaring For ANI Pharma, CEO Says Well-Positioned To Mitigate Potential Tariff Impact

Benzinga
·
10 May

Stock Track | ANI Pharmaceuticals Plummets 5.14% Despite Strong Q1 Earnings and Raised Guidance

Stock Track
·
09 May

BUZZ-ANI Pharma rises after lifting 2025 forecasts

Reuters
·
09 May

ANI Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
09 May

Sector Update: Health Care Stocks Flat to Higher Premarket Friday

MT Newswires Live
·
09 May

Stock Track | ANI Pharmaceuticals Soars 6.25% Pre-market on Record Q1 Results and Raised 2025 Guidance

Stock Track
·
09 May

Stock Track | ANI Pharmaceuticals Soars 6.25% Pre-Market on Strong Q1 Results and Raised 2025 Guidance

Stock Track
·
09 May

ANI Pharmaceuticals Q1 Adjusted Earnings, Revenue Rise; 2025 Outlook Raised

MT Newswires Live
·
09 May

ANI Pharmaceuticals Shares up 3.5% Premarket After Co Lifts 2025 Profit Forecast

THOMSON REUTERS
·
09 May

ANI Pharmaceuticals Q1 2025 Adj. EPS $1.70 Beats $1.38 Estimate, Sales $197.12M Beat $180.68M Estimate

Benzinga
·
09 May

BRIEF-ANI Pharmaceuticals Q1 Adjusted EPS USD 1.7 Vs. IBES Estimate USD 1.38

Reuters
·
09 May

ANI Pharmaceuticals Outlook FY Adjusted EPS USD 6.27-6.62

THOMSON REUTERS
·
09 May

ANI Pharmaceuticals Inc - 2025 Guidance Raised, Expected Net Revenues $768-$793 Million

THOMSON REUTERS
·
09 May

ANI Pharmaceuticals Q1 Revenue USD 68.959 Million VS. Ibes Estimate USD 180.7 Million

THOMSON REUTERS
·
09 May

ANI Pharmaceuticals Reports Record First Quarter 2025 Financial Results and Raises 2025 Guidance

THOMSON REUTERS
·
09 May

ANI Pharmaceuticals to Report Q1 Earnings: Is a Beat in the Cards?

Zacks
·
06 May

ANI Pharmaceuticals Announces Presentation of Preclinical Data on the Use of Purified Cortrophin® Gel in an Experimental Autoimmune Uveitis (EAU) Mouse Model

GlobeNewswire
·
05 May

ANI Pharmaceuticals (ANIP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Zacks
·
02 May